P3

Lessons in perinatal psychology after 19 months of COVID-19

Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on practicing perinatal psychiatry during the ongoing COVID-19 pandemic with Ob.Gyn News on November [...]

By |2021-12-09T12:32:41-04:00December 6th, 2021|ObGyn News, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Lessons in perinatal psychology after 19 months of COVID-19

Toward a clearer risk model for postpartum psychosis

Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on mitigating psychiatric relapse during pregnancy amidst the COVID-19 pandemic with Ob.Gyn News on [...]

By |2021-11-22T12:40:57-04:00August 21st, 2021|Postpartum Psychiatric Disorders, Postpartum Psychosis|Comments Off on Toward a clearer risk model for postpartum psychosis

Essential Reads: Phenomenology, Epidemiology and Aetiology of Postpartum Psychosis: A Review

Postpartum psychosis affects 1 to 2 per 1000 women after childbirth.  About 40% of women who experience postpartum psychosis do not have a history of psychiatric illness; however, women with bipolar disorder or a history [...]

By |2021-05-06T15:08:11-04:00January 27th, 2021|Essential Reads, Postpartum Psychiatric Disorders, Postpartum Psychosis|Comments Off on Essential Reads: Phenomenology, Epidemiology and Aetiology of Postpartum Psychosis: A Review

Long-Term Outcomes of Postpartum Psychosis: What is the Risk of Recurrence?

Postpartum psychosis is the most severe form of postpartum psychiatric illness. It occurs in fewer than one out of every 1000 women after childbirth. Many women who have suffered from postpartum psychosis (PP) wonder [...]

By |2025-09-03T16:49:26-04:00May 6th, 2020|Postpartum Psychiatric Disorders, Postpartum Psychosis|Comments Off on Long-Term Outcomes of Postpartum Psychosis: What is the Risk of Recurrence?

Zulresso: Hope and lingering questions

Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the new postpartum depression medication Zulresso (brexanolone) with Ob.Gyn News on August 20th, [...]

By |2021-11-22T14:52:23-04:00September 10th, 2019|Medication, ObGyn News, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Zulresso: Hope and lingering questions
Go to Top